Gallbladder Cancer
📧 Sign up to get email alerts when something new happens for Gallbladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma [EARLY_Phase 1]
This update covers an early-phase Phase 1 trial to assess the safety and feasibility of heated intraperitoneal chemotherapy (HIPEC) for high…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer [Phase 2]
A Phase II clinical trial is evaluating iparomlimab and tuvonralimab (QL1706) in combination with albumin-bound paclitaxel and lenvatinib as…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies [Phase 1, Phase 2]
This Clinical Trial Update describes a Phase 1/2 study of the ATR inhibitor peposertib in combination with the PD-L1 inhibitor avelumab and …
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
A completed study comparing TDTP-RECIST with RECIST 1.1 and other volumetric methods to evaluate therapeutic response in irregular malignant…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering [Phase 1, Phase 2]
A Phase 1/2 study evaluating autologous tumor-infiltrating lymphocytes edited by CRISPR to inhibit CISH for metastatic gastrointestinal canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types [Phase 1, Phase 2]
This update reports a Phase 1/2 trial of atezolizumab plus tivozanib in several immunologically cold tumor types, with the study currently s…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer. [Phase 2]
Phase 2 trial evaluating nivolumab plus relatlimab with gemcitabine/cisplatin as first-line treatment for advanced biliary tract cancer; the…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Pembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with lenvatinib for advanced biliary tract carcinoma. The study has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
The PERSUASION registry, a prospective German platform for biliary tract cancers including gallbladder carcinoma, has completed its expanded…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer [Phase 2]
Phase 2 clinical trial update for a regimen of gemcitabine and nab-paclitaxel with iparomlimab and tuvorilimab in unresectable advanced gall…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Study of ACC-1898 in Adult Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study update for ACC-1898 in adults with advanced solid tumors; the trial is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract [Phase 2]
Phase 2 trial of Taxoprexin for advanced primary cancers of the liver, gallbladder, or biliary tract was terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers [Phase 2]
Phase 2 trial evaluating tucatinib plus trastuzumab with oxaliplatin-based chemotherapy or pembrolizumab-containing regimens for HER2-positi…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
A completed clinical trial update describing biomarker discovery efforts in patients with advanced biliary tract cancer, including cholangio…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: The Safety and Efficacy of Benmelstobart Injection in Patients With Advanced Biliary Tract Malignant Tumors [Phase 2]
A Phase 2 clinical trial is evaluating Benmelstobart Injection for advanced biliary tract cancers and the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder [Phase 1]
A Phase 1 study evaluating DKN-01 in combination with gemcitabine and cisplatin for biliary tract cancers has completed (completion status r…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer
This clinical trial update reports the completion of a study evaluating an AI-based analysis of the tumor microenvironment to predict progno…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
This clinical trial update reports the termination of a feasibility study evaluating multi-platform profiling of resected biliary tract canc…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Predicting Incidental Gallbladder Cancer
Clinical trial update for 'Predicting Incidental Gallbladder Cancer' sponsored by University Hospital Plymouth NHS Trust; the study is activ…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating atezolizumab plus varlilumab with or without cobimetinib in advanced biliary tract cancers, with results posted in …
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT) [Phase 2]
Phase 2 trial update for a four-drug regimen (gemcitabine, nab-paclitaxel, lenalidomide, and tislelizumab) in advanced unresectable biliary …
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating durvalumab and tremelimumab with or without capecitabine as adjuvant therapy for biliary tract cancers; th…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Clinical Correlation Study Between Anomalous Pancreaticobiliary Ductal Junction and Malignant Tumors of the Biliary System and the Establishment of an AI-based Automated Recognition System
This completed clinical trial investigated the relationship between anomalous pancreaticobiliary ductal junction and malignant tumors of the…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) [NA]
PLATON, a platform for analyzing targetable tumor mutations, completed its pilot study evaluating its utility across hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Global Evaluation of Cholecystectomy Knowledge and Outcomes
A completed clinical trial evaluating global knowledge about cholecystectomy and its outcomes. Conditions include gallstone disease, gallbla…